[go: up one dir, main page]

SI9210065B - Novel antiinflamatory and antialergic active compounds, glucocorticosteroids and processes for their preparation - Google Patents

Novel antiinflamatory and antialergic active compounds, glucocorticosteroids and processes for their preparation Download PDF

Info

Publication number
SI9210065B
SI9210065B SI9210065A SI9210065A SI9210065B SI 9210065 B SI9210065 B SI 9210065B SI 9210065 A SI9210065 A SI 9210065A SI 9210065 A SI9210065 A SI 9210065A SI 9210065 B SI9210065 B SI 9210065B
Authority
SI
Slovenia
Prior art keywords
compound
formula
preparation
compound according
epimer
Prior art date
Application number
SI9210065A
Other languages
English (en)
Slovenian (sl)
Other versions
SI9210065A (en
Inventor
Paul Hakan Andersson
Bengt Ingemar Axelsson
Ralph Lennart Brattsand
Arne Bror Thalen
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of SI9210065A publication Critical patent/SI9210065A/sl
Publication of SI9210065B publication Critical patent/SI9210065B/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0092—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI9210065A 1991-02-04 1992-01-22 Novel antiinflamatory and antialergic active compounds, glucocorticosteroids and processes for their preparation SI9210065B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9100341A SE9100341D0 (sv) 1991-02-04 1991-02-04 Novel steroids
YU6592A YU48892B (sh) 1991-02-04 1992-01-22 Novi steroidi

Publications (2)

Publication Number Publication Date
SI9210065A SI9210065A (en) 1995-02-28
SI9210065B true SI9210065B (en) 2001-12-31

Family

ID=20381806

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9210065A SI9210065B (en) 1991-02-04 1992-01-22 Novel antiinflamatory and antialergic active compounds, glucocorticosteroids and processes for their preparation

Country Status (40)

Country Link
US (2) US5674861A (de)
EP (1) EP0570454B1 (de)
JP (1) JPH06505232A (de)
KR (1) KR100216720B1 (de)
CN (3) CN1034868C (de)
AP (1) AP366A (de)
AT (1) ATE178611T1 (de)
BG (1) BG62211B1 (de)
CA (1) CA2103924A1 (de)
CZ (1) CZ281685B6 (de)
DE (1) DE69228870T2 (de)
DK (1) DK0570454T3 (de)
DZ (1) DZ1553A1 (de)
EE (1) EE03111B1 (de)
ES (1) ES2133315T3 (de)
FI (1) FI933450A0 (de)
GR (1) GR3030657T3 (de)
HK (1) HK1010733A1 (de)
HU (1) HU218275B (de)
IE (1) IE920166A1 (de)
IL (1) IL100532A (de)
IS (1) IS1601B (de)
MA (1) MA22406A1 (de)
MX (1) MX9200324A (de)
NO (1) NO304073B1 (de)
NZ (1) NZ241210A (de)
PH (1) PH31284A (de)
PL (1) PL170000B1 (de)
PT (1) PT100086B (de)
RO (1) RO111195B1 (de)
RU (1) RU2111212C1 (de)
SE (1) SE9100341D0 (de)
SG (1) SG52557A1 (de)
SI (1) SI9210065B (de)
SK (1) SK281801B6 (de)
TN (1) TNSN92007A1 (de)
UA (1) UA41267C2 (de)
WO (1) WO1992013872A1 (de)
YU (1) YU48892B (de)
ZA (1) ZA92233B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100341D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroids
DK0678097T3 (da) * 1993-01-08 2000-02-07 Astra Ab Hidtil ukendte colon- eller ileumspecifikke steroidderivater
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
US5983956A (en) 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
GB9423919D0 (en) * 1994-11-26 1995-01-11 Rhone Poulenc Rorer Ltd Chemical process
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
IT1291288B1 (it) 1997-04-30 1999-01-07 Farmabios Srl Processo per la preparazione di 16,17 acetali di derivati pregnanici con controllo della distribuzione epimerica al c-22.
DE69942578D1 (de) 1998-05-22 2010-08-26 Univ R Bifunktionelle moleküle sowie darauf basierende therapien.
GB0009592D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
GB0009607D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Medical compositions
HRP20010018A2 (en) 2001-01-09 2002-12-31 Pliva D D Novel anti-inflammatory compounds
GB0110411D0 (en) * 2001-04-27 2001-06-20 Astrazeneca Ab Chemical process
JP2005505578A (ja) * 2001-09-25 2005-02-24 ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー ステロイドｃ−２２位アセトニドの立体選択的トランスアセタール化
WO2004005310A2 (en) 2002-07-08 2004-01-15 Pliva-Istrazivacki Institut D.O.O. New compounds, compositions and methods for treatment of inflammatory diseases and conditions
AU2003264917A1 (en) 2002-07-08 2004-01-23 Pliva - Istrazivacki Institut D.O.O. Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules
US20040157810A1 (en) * 2002-08-23 2004-08-12 Teicher Martin H. Corticosteroid conjugates and uses thereof
TW200417371A (en) * 2003-02-21 2004-09-16 Upjohn Co A continuous process for the production of R-rofleponide
HRP20030324A2 (en) 2003-04-24 2005-02-28 Pliva-Istra�iva�ki institut d.o.o. Compounds of antiinflammatory effect
HRP20030604A2 (en) 2003-07-25 2005-04-30 Pliva-Istra�iva�ki institut d.o.o. Substituted furochromenes, preparation thereof andtheir antiinflammatory action
HRP20030603A2 (en) 2003-07-25 2005-10-31 Pliva-Istra�iva�ki institut d.o.o. Substituted furochromene compounds of antiinflammatory action
CN101090908A (zh) 2004-10-27 2007-12-19 葛兰素伊斯特拉齐瓦基森塔萨格勒布公司 具有抗炎活性的共轭物
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
US20080207577A1 (en) * 2005-07-11 2008-08-28 Astrazeneca Ab Combination I
US9062126B2 (en) 2005-09-16 2015-06-23 Raptor Pharmaceuticals Inc. Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof
WO2008100560A2 (en) * 2007-02-14 2008-08-21 University Of Southern California Estrogen receptor modulators, associated pharmaceutical compositions and methods of use
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
MY163048A (en) 2009-05-06 2017-08-15 Laboratory Skin Care Inc Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3126375A (en) * 1964-03-24 Chioacyl
US3048581A (en) * 1960-04-25 1962-08-07 Olin Mathieson Acetals and ketals of 16, 17-dihydroxy steroids
US3357974A (en) * 1965-12-28 1967-12-12 Merck & Co Inc Processes for preparing 16alpha, 17alpha-acetals and ketals of 16alpha, 17alpha, 21-trihydroxy-delta4-pregnene-3, 20-diones
US3758686A (en) * 1971-12-07 1973-09-11 American Cyanamid Co Method of using steroid acetonides
SE378109B (de) * 1972-05-19 1975-08-18 Bofors Ab
SE378110B (de) * 1972-05-19 1975-08-18 Bofors Ab
SE8008524L (sv) * 1980-12-04 1982-06-05 Draco Ab 4-pregnen-derivat, ett forfarande for deras framstellning, beredning och metod for behandling av inflammatoriska tillstand
US4749649A (en) * 1983-05-16 1988-06-07 The Upjohn Company Microbial Δ1-dehydrogenation process using a scavenger of toxic oxygen
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
SE8403905D0 (sv) * 1984-07-30 1984-07-30 Draco Ab Liposomes and steroid esters
CN1060471A (zh) * 1985-04-04 1992-04-22 得拉科公司 新的16，17-缩醛取代雄甾烷-17β-酮类的制备方法
SE8604059D0 (sv) * 1986-09-25 1986-09-25 Astra Pharma Prod A method of controlling the epimeric distribution in the preparation of 16,17-acetals of pregnane derivatives
HU203562B (en) * 1989-03-09 1991-08-28 Richter Gedeon Vegyeszet Process for producing new steroide diols and pharmaceutical compositions containing them
HU203769B (en) * 1989-03-09 1991-09-30 Richter Gedeon Vegyeszet Process for producing new steroide derivatives and pharmaceutical compositions containing them
PL164294B1 (pl) * 1990-12-20 1994-07-29 Inst Farmaceutyczny Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL
SE9100341D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroids
SE9100342D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroid esters

Also Published As

Publication number Publication date
CN1058724C (zh) 2000-11-22
SK281801B6 (sk) 2001-08-06
YU6592A (sh) 1995-01-31
EP0570454B1 (de) 1999-04-07
CN1140178A (zh) 1997-01-15
CN1140059A (zh) 1997-01-15
EP0570454A1 (de) 1993-11-24
RO111195B1 (ro) 1996-07-30
CN1052155C (zh) 2000-05-10
AP366A (en) 1994-10-21
TNSN92007A1 (fr) 1993-06-08
PT100086A (pt) 1994-05-31
HU218275B (en) 2000-07-28
IS3808A (is) 1992-08-05
BG97971A (bg) 1994-04-29
MA22406A1 (fr) 1992-10-01
BG62211B1 (bg) 1999-05-31
ES2133315T3 (es) 1999-09-16
NZ241210A (en) 1993-08-26
US5674861A (en) 1997-10-07
IL100532A (en) 1996-05-14
KR100216720B1 (ko) 1999-10-01
ZA92233B (en) 1992-10-28
EE03111B1 (et) 1998-08-17
FI933450A (fi) 1993-08-03
NO932761D0 (no) 1993-08-02
MX9200324A (es) 1992-09-01
HU9302244D0 (en) 1993-10-28
IS1601B (is) 1996-10-18
IL100532A0 (en) 1992-09-06
SG52557A1 (en) 1998-09-28
RU2111212C1 (ru) 1998-05-20
CN1034868C (zh) 1997-05-14
IE920166A1 (en) 1992-08-12
CZ149693A3 (en) 1994-03-16
AU1230792A (en) 1992-09-07
CN1064079A (zh) 1992-09-02
YU48892B (sh) 2002-10-18
AU661471B2 (en) 1995-07-27
NO304073B1 (no) 1998-10-19
PH31284A (en) 1998-07-06
SE9100341D0 (sv) 1991-02-04
SI9210065A (en) 1995-02-28
ATE178611T1 (de) 1999-04-15
SK79693A3 (en) 1994-03-09
CA2103924A1 (en) 1992-08-05
NO932761L (no) 1993-08-02
PL170000B1 (pl) 1996-10-31
JPH06505232A (ja) 1994-06-16
DZ1553A1 (fr) 2002-02-17
HUT64973A (en) 1994-03-28
AP9200353A0 (en) 1992-01-31
FI933450A0 (fi) 1993-08-03
PT100086B (pt) 1999-06-30
WO1992013872A1 (en) 1992-08-20
GR3030657T3 (en) 1999-10-29
DE69228870T2 (de) 1999-08-19
DK0570454T3 (da) 1999-10-18
US5939409A (en) 1999-08-17
DE69228870D1 (de) 1999-05-12
UA41267C2 (uk) 2001-09-17
HK1010733A1 (en) 1999-06-25
CZ281685B6 (cs) 1996-12-11

Similar Documents

Publication Publication Date Title
SI9210065B (en) Novel antiinflamatory and antialergic active compounds, glucocorticosteroids and processes for their preparation
DE60013266T2 (de) Steroidnitrate zur behandlung von oxidativen schädigungen und endothelialer dysfunktion
PL121569B1 (en) Process for preparing novel esters of 4-halogen-3-oxoandrosteno-4-carbo-17-beta-thiolic acidten-4-karbotiolovojj kisloty
DE69527980T2 (de) Chalcone und ihre ester mit antiproliferativer aktivität in gebärmutter, ovar- und brusttumoren
JPS6114159B2 (de)
EP0029247B1 (de) Alkenyl-thienyl-alkancarbonsäuren und ihre Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
Bundy et al. Synthesis and biological activity of prostaglandin lactones
AU660870B2 (en) Novel esculetin derivatives and pharmaceutical composition
US3723484A (en) 17-chloro steroids
HU179069B (en) Process for preparing 1,3/diesters with benzoic acid of 17alpha-ethynyl-7alpha-methyl-1,3,5/10/-estratriene-1,3,17beta-triol
US5266566A (en) Method of treating fungal infections using sterodial ester compounds
US4107161A (en) Bis(triamcinolone acetonide)-4,4'-methylenebis-(3-methoxy-2-naphthoate)
EP0009777A1 (de) Retinsäure- und 7,8-Dehydro-retinsäure-N-(carboxy)-phenyl-amide, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
US3899581A (en) Triamcinolone acetonide derivative
DE2001305C3 (de) Cytostatisch wirksame Corticosteroid-21 -ester, deren Herstellung sowie diese enthaltende Arzneimittel
DE69104485T2 (de) Von dialkylaminoalkyl-26-sulfonylpristinamycin iib abgeleitete salze.
US3317384A (en) Treatment of topical viral infections with glucocorticoids and nucleosides
HU196122B (en) Process for preparing pharmaceuticals comprising 9alpha, 11beta-dichlor-16alpha-methyl-21-(dicyclohexyl-methyloxy-carbonyloxy)-pregno-1,4-dien-3,20-dione
DE69206321T2 (de) Ursane Derivate, ihre Herstellung und die enthaltende pharmazeutische Zusammensetzung.
DE2709078C2 (de) Neue Halogen-Derivate der Reihe des 16α-Methylpregnans, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
US3025311A (en) Hydrocortisone 21-beta beta-dimethyl glutarate and derivatives thereof
US3857941A (en) Pharmaceutical compositions and use of prednisolone 17-benzoate
US3674817A (en) Nitro-steroids and process for their preparation
JPS5877900A (ja) ２−ブロム−６β−フルオル−１，４−プレグナジエン−３，２０−ジオン類の製造方法
GB1593978A (en) Anti-inflammatory steroids